Topic: neurodegenerative diseases
The week’s biotech discoveries included compounds in broccoli and ragweed with potential disease-fighting properties.
Skyhawk Therapeutics is teaming up with Takeda to develop small molecules that correct RNA mis-splicing in neurodegenerative disease.
Maryland researchers discovered a type of stem cell in hair follicles that can rebuild the myelin that breaks down in brain diseases like multiple sclerosis.
Charles River Labs and the CHDI Foundation have signed a five-year extension for their Huntington’s disease work.
The cash will fund midphase trials of an ex-Vertex drug in dementia and Huntington's disease.
The company says its new name aligns with its focus on developing regenerative therapies for diseases such as Alzheimer’s and Parkinson’s.
Inhibiting CD22 may help treat or prevent neurodegenerative diseases by restoring the brain's microglia, a Stanford team found.
Illumina plans to help map thousands of years of DNA fragments in a hunt for clues into today’s mental health issues and neurological conditions.
French biotech AlzProtect has teamed up with CRO Parexel for its midstage test of AZP2006 in patients with progressive supranuclear palsy.
Based on phase 2 data, a Georgetown University team showed that Tasigna reduces toxic protein clumps and restores dopamine metabolism in Parkinson's.